(May 17, 2019) - - Today (May 17, 2019), the Centers for Medicare and Medicaid Services (CMS) published the following information:
Delay in Final Chimeric Antigen Receptor (CAR) T-cell therapy National Coverage Determination
From a CMS spokesperson:
“CMS will not be issuing a final National Coverage Determination on CAR T-cell therapy for cancer today, but a decision is forthcoming.”
To read the proposed decision, visit the CMS website at:
https://www.cms.gov/medicare-coverag...aspx?NCAId=291
Comments may be viewed in their entirety by using the following link: https://www.cms.gov/medicare-coverag...aspx?NCAId=291 .
.
Rate this article